Zosano Pharma Corp Deferred Tax Assets, Valuation Allowance
Zosano Pharma Corp had Deferred Tax Assets, Valuation Allowance of $38.46 million as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-03-17
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $38.46M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $30.30M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $27.45M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $16.54M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2021-12-31 | $38.46M 10-K · filed 2022-03-17 |
| 2020-12-31 | $30.30M 10-K · filed 2022-03-17 |
| 2019-12-31 | $27.45M 10-K · filed 2021-03-11 |
| 2018-12-31 | $16.54M 10-K · filed 2020-03-13 |
| 2018-09-30 | $400.00K 10-K · filed 2018-03-12 |
| 2017-12-31 | $16.85M 10-K · filed 2019-03-25 |
| 2016-12-31 | $18.95M 10-K · filed 2018-03-12 |
| 2015-12-31 | $75.84M 10-K · filed 2017-03-01 |
| 2014-12-31 | $62.18M 10-K · filed 2016-03-29 |